Kessler Topaz Meltzer & Check, LLP - Deadline Reminder for CenturyLink, Inc. Shareholders – CTL
Aug 02, 2017 15:11 pm UTC| Business
RADNOR, Pa., Aug. 02, 2017 -- Kessler Topaz Meltzer Check, LLP reminds CenturyLink, Inc. (NYSE:CTL) (“CenturyLink” or the “Company”) shareholders that class action lawsuits have been filed in the United States District...
TriCore Announces David G. Grenache, PhD, as Chief Scientific Officer
Aug 02, 2017 15:07 pm UTC| Business
Albuquerque, New Mexico, Aug. 02, 2017 -- TriCore Reference Laboratories announced today that David G. Grenache, PhD; has been selected as its first Chief Scientific Officer, effective September 2017. ...
AEROMEXICO AND EL AL ISRAEL AIRLINES SIGN A CODE SHARE AGREEMENT
Aug 02, 2017 15:06 pm UTC| Business
Mexico City / Tel Aviv, Aug. 02, 2017 -- Mexico City/ Tel Aviv.- August 2, 2017. – Aeromexico, Mexico’s global airline, launched the new code share agreement it signed with EL AL Israel Airlines during the IATA Annual...
Bioline Launches New JetSeq™ Clean Kit for Next-Generation Sequencing
Aug 02, 2017 15:05 pm UTC| Business
CINCINNATI, Aug. 02, 2017 -- Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the further expansion of the JetSeq™ portfolio today for Next-Generation...
THINKFUN DEBUTS A TARGET EXCLUSIVE LINE OF UNPLUGGED CODING GAMES
Aug 02, 2017 15:05 pm UTC| Business
ALEXANDRIA, Va., Aug. 02, 2017 -- FOR IMMEDIATE RELEASE ThinkFun releases new //CODE board game series exclusively at Target stores nationwide. The coding board games, ‘On the Brink,’ ‘Rover Control,’ and ‘Robot Repair’...
Alamo Pharma Services Chief Operating Officer named to PharmaVOICE 100 most inspiring people
Aug 02, 2017 15:04 pm UTC| Business
DOYLESTOWN, Pa., Aug. 02, 2017 -- Alamo Pharma Services, Inc. (“Alamo”) is pleased to announce that its Chief Operating Officer, Peter Marchesini, has been named to PharmaVOICE magazine’s annual list of 100 most...
Aug 02, 2017 15:00 pm UTC| Business
LONDON, Aug. 02, 2017 -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases,...